for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Taro Pharmaceutical Industries Ltd.

TARO.N

現在値

74.44USD

変化

-0.39(-0.52%)

出来高

1,296

本日のレンジ

74.30

 - 

74.65

52週レンジ

54.04

 - 

80.00

∙ 約20分前の相場を表示しています。

適時開示

Taro Posts Quarterly Loss Per Share Of $0.78

May 19 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::TARO PROVIDES RESULTS FOR THE YEAR ENDED MARCH 31, 2021.Q4 SALES $148.3 MILLION.QTRLY LOSS PER SHARE $0.78.

Taro Pharmaceutical Industries Quarterly Sales $140.1 Million

Jan 27 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::QUARTERLY SALES $140.1 MILLION.QTRLY EARNINGS PER SHARE $0.86.

Taro Pharmaceutical Posts Quarterly Earnings Per Share $1.18

Oct 28 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::QUARTERLY EARNINGS PER SHARE $1.18.QUARTERLY SALES $142.8 MILLION.QTRLY NET SALES OF $142.8 MILLION DECREASED $18.0 MILLION.

Taro Pharmaceutical Launches Specialty Generic Deferiprone Tablets, 500Mg In U.S.

Sept 28 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::TARO PHARMACEUTICAL INDUSTRIES LTD - LAUNCHES SPECIALTY GENERIC DEFERIPRONE TABLETS, 500MG IN U.S..

Taro Provides Results For Quarter Ended June 30, 2020

July 29 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::TARO PROVIDES RESULTS FOR QUARTER ENDED JUNE 30, 2020.QUARTERLY SALES $117.6 MILLION.QUARTERLY EARNINGS PER SHARE $0.76 EXCLUDING ITEMS.ON JULY 23 ACHIEVES GLOBAL RESOLUTION OF DOJ ANTITRUST INVESTIGATIONS.TARO PHARMACEUTICALS U.S.A., AGREED TO PAY $213.3 MILLION TO RESOLVE CLAIMS RELATED TO FEDERAL HEALTHCARE PROGRAMS.CHARGE OF $418.9 MILLION IS TAKEN IN CURRENT QUARTER RELATED TO SETTLEMENT UNDER DOJ ANTITRUST INVESTIGATIONS.

Sun Pharma Unit To Acquire Aquinox Pharmaceuticals (Canada)

July 29 (Reuters) - Sun Pharmaceutical Industries Ltd <SUN.NS>::TARO PHARMACEUTICAL INDUSTRIES AGREED TO ACQUIRE BY WAY OF PURCHASE OF ALL OUTSTANDING SHARES OF AQUINOX PHARMACEUTICALS.SAYS DEAL FOR $8.2 MILLION.

Taro Reports Q4 Earnings Per Share Of $1.42

May 19 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::TARO PROVIDES RESULTS FOR THE YEAR ENDED MARCH 31, 2020.Q4 EARNINGS PER SHARE $1.42.Q4 SALES $174.9 MILLION.

Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall Of Phenytoin Oral Suspension USP, 125 Mg/5 Ml

Feb 20 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::TARO PHARMACEUTICALS U.S.A. ISSUES VOLUNTARY NATIONWIDE RECALL OF PHENYTOIN ORAL SUSPENSION USP, 125 MG/5 ML DUE TO POSSIBLE UNDERDOSING OR OVERDOSING.TARO PHARMACEUTICALS U.S.A - RECALLED LOTS OF PHENYTOIN ORAL SUSPENSION MAY NOT RE-SUSPEND WHEN SHAKEN, WHICH COULD RESULT IN UNDER OR OVERDOSING.TARO PHARMACEUTICALS U.S.A - RECALL IS BEING CONDUCTED WITH KNOWLEDGE OF FDA.

Taro Pharmaceutical Industries Reports Q3 Sales $147.7 Million

Feb 3 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::Q3 SALES $147.7 MILLION.QTRLY EARNINGS PER SHARE $1.76.

Taro Announces Resignation Of Chief Financial Officer

Dec 6 (Reuters) - Taro Pharmaceutical Industries Ltd <TARO.N>::TARO ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER.TARO PHARMACEUTICAL INDUSTRIES LTD - BALAGUER IS LEAVING TO ACCEPT POSITION OF CFO AT ANOTHER COMPANY.TARO PHARMACEUTICAL INDUSTRIES LTD - ACCEPTED RESIGNATION OF ITS CFO, MARIANO BALAGUER, EFFECTIVE JANUARY 3, 2020.TARO PHARMACEUTICAL INDUSTRIES LTD - COMPANY HAS INITIATED A SEARCH FOR A SUCCESSOR AS CFO.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up